3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Male Urogenital Diseases
1
Lymphedema
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Financial Stress
1
Female Urogenital Diseases
1
Endometrial Neoplasms
1
Encopresis
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Interventions
Capecitabine
22
Oxaliplatin
19
Fluorouracil
16
Radiotherapy
11
Leucovorin
10
Cetuximab
9
Nivolumab
7
Bevacizumab
6
sintilimab
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
pembrolizumab
4
Surgical Procedures, Operative
4
encorafenib
3
X-Rays
3
Trastuzumab
3
Surveys and Questionnaires
3
Sigmoidoscopy
3
Radiation
3
Pemetrexed
3
Gemcitabine
3
Endoscopy
3
Control Groups
3
Consolidation Chemotherapy
3
Cisplatin
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Radiation Dose Hypofractionation
×
90 days
×
Clear all
No trials found.